Lead Product(s): Oxiconazole Nitrate
Therapeutic Area: Infections and Infectious Diseases Product Name: Oxistat
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: ANI Pharmaceuticals Inc
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition April 06, 2021
ANI Pharmaceuticals has acquired new drug applications for OXISTAT Lotion, VEREGEN Ointment, and Pandel Cream and the abbreviated new drug application for ApexiCon E Cream from Sandoz Inc. Pandel Cream will be transitioned later upon receiving the requisite approvals.